EVE Health Group Limited (AU:EVE)
ASX:EVE
Want to see AU:EVE full AI Analyst Report?
EVE Stock Chart & Stats
AU$0.02
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.02
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.02 - AU$0.04
Previous CloseN/A
Volume9.81K
Average Volume (3M)774.07K
Market Cap
AU$8.46M
Enterprise ValueAU$4.30M
Total Cash (Recent Filing)AU$929.66K
Total Debt (Recent Filing)AU$38.51K
Price to Earnings (P/E)―
Beta0.44
Next Earnings
Sep 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding352,326,600
10 Day Avg. Volume491,958
30 Day Avg. Volume774,070
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)1.22
Price to Sales (P/S)2.49
P/FCF Ratio-2.68
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low Leverage / Conservative Capital StructureA debt-to-equity ratio of 0.03 indicates very low leverage, which materially reduces default and refinancing risk. Over a 2-6 month horizon this financial conservatism preserves flexibility to fund operations or strategic moves while management addresses profitability, a durable stability factor.
Improving Free Cash Flow GrowthReported improvement in free cash flow growth signals the business is starting to generate more cash after investment. If sustained, that reduces reliance on external financing, enables targeted reinvestment or debt reduction, and strengthens resilience during a multi-month turnaround.
Stable Equity Base / Solid Equity RatioA stable equity ratio provides a lasting capital cushion to absorb near-term losses and supports solvency during operational restructuring. This durable balance-sheet strength gives management time to implement recovery plans without immediate liquidity-driven distress.
Bears Say
Declining Revenue TrendMaterial and ongoing top-line decline undermines scale economics and makes margin recovery difficult. Sustained revenue contraction over months hampers pricing power and unit-cost dilution, increasing the difficulty of restoring profitable operations and predictable cash generation.
Persistent Negative ProfitabilityConsistent negative net margins and negative ROE indicate the business cannot convert sales into shareholder returns. This structural unprofitability erodes equity, limits internal funding for growth or fixes, and implies the need for substantive operational or strategic changes to regain sustainability.
Negative Operating Cash Flow / Weak Cash ConversionPersistent negative operating cash flow and poor cash conversion constrain liquidity and operational flexibility. Over a medium horizon this forces reliance on external financing or asset sales, which can be costly and impede necessary investments to reverse revenue and margin declines.
EVE Health Group Limited News
EVE FAQ
What was EVE Health Group Limited’s price range in the past 12 months?
EVE Health Group Limited lowest share price was AU$0.02 and its highest was AU$0.04 in the past 12 months.
What is EVE Health Group Limited’s market cap?
EVE Health Group Limited’s market cap is AU$8.46M.
When is EVE Health Group Limited’s upcoming earnings report date?
EVE Health Group Limited’s upcoming earnings report date is Sep 02, 2026 which is in 87 days.
How were EVE Health Group Limited’s earnings last quarter?
EVE Health Group Limited released its earnings results on Feb 27, 2026. The company reported -AU$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.003.
Is EVE Health Group Limited overvalued?
According to Wall Street analysts EVE Health Group Limited’s price is currently Overvalued.
Does EVE Health Group Limited pay dividends?
EVE Health Group Limited does not currently pay dividends.
What is EVE Health Group Limited’s EPS estimate?
EVE Health Group Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does EVE Health Group Limited have?
EVE Health Group Limited has 352,326,600 shares outstanding.
What happened to EVE Health Group Limited’s price movement after its last earnings report?
EVE Health Group Limited reported an EPS of -AU$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of EVE Health Group Limited?
Currently, no hedge funds are holding shares in AU:EVE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
EVE Health Group Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bearish
AU:EVE Sentiment 100%
Sector Average ―
Sector Average ―
Insider Transactions
Bought Shares
Worth AU$27.9K over
the Last 3 Months
the Last 3 Months
Fundamentals
Return on Equity
-44.35%
Trailing 12-Months
Asset Growth
348.70%
Trailing 12-Months
Company Description
EVE Health Group Limited
Eve Health Group Limited, together with its subsidiaries, engages in the production and distribution of nutrition, health, and wellness products in Australia, New Zealand, the Asia Pacific, and North America. It provides organic tea tree oils; and distributes botanical oils, as well as supplies essential oils, hydrosols, extracts, carrier oils, and seed oils. The company also offers organic raw honey and raw honey probiotic concentrates; and contract manufacturing services. In addition, it offers medical nutrition solutions for chronic and lifestyle diseases, including Gluco Smooth for type 2 diabetes that reduces the post-meal blood sugar levels; and dietary interventions. The company was formerly known as EVE Investments Limited. Eve Health Group Limited was incorporated in 2003 and is based in Subiaco, Australia.
Technical Analysis
―
Fiji Kava Limited
―
Holista Colltech Limited
―
Nutritional Growth Solutions Ltd.
―
Forbidden Foods Ltd
―
Options Prices
Currently, No data available
---